FILINGS
| GSK 0001131399 | |||
|---|---|---|---|
| Filing Date | Form Type | Description | Document |
| 2022-02-10 | SC 13G/A | AMENDMENT TO SC 13G | View Document |
| 2022-02-10 | SC 13G | SCHEDULE 13G | View Document |
| 2022-02-10 | SC 13G/A | AMENDMENT TO SC 13G | View Document |
| 2022-02-10 | SC 13D/A | AMENDMENT TO FORM SC 13D | View Document |
| 2022-02-10 | SC 13G/A | AMENDMENT TO FORM SC 13G | View Document |
| 2022-02-10 | 6-K | BENLYSTA APPROVED IN CHINA FOR LUPUS NEPHRITIS | View Document |
Search company filings and access detailed reports including 10-K, 10-Q, 8-K, and other critical filings. Stay informed on corporate disclosures, regulatory filings, and updates with our easy-to-use EDGAR API filings search tool.
